当前位置: X-MOL 学术Gen. Thorac. Cardiovasc. Surg. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinical efficacy of digital chest drainage system in cardiac valve surgery
General Thoracic and Cardiovascular Surgery ( IF 1.1 ) Pub Date : 2021-11-29 , DOI: 10.1007/s11748-021-01752-9
Kiyoshi Tamura 1 , Shogo Sakurai 1
Affiliation  

Objects

The portable digitalized suction was used widely in thoracic surgery. The aim of the study was to access the early outcomes of using the portable digitalized suction system after cardiac surgery.

Methods

We invested 80 patients including 30 women (mean age 72.7 ± 9.2 years) who underwent cardiac surgery at our hospital, excluded coronary artery bypass grafting only, with or only aortic surgery, emergency operation, and patients with hemodialysis. Patients were categorized as those treated with digital chest drainage system (DCS group, n = 38) or analog chest drainage system (ACS group, n = 42), and the following data were analyzed in two groups. The primary endpoint was the duration of chest drainage, and the secondary endpoints were the rate of drainage-related complications and the length of hospitalization.

Results

The duration of drainage was significantly shorter in the DCS group (ACS vs. DCS = 94.8 ± 31.5 vs. 81.1 ± 20.6 h, p = 0.036). The duration needed for rehabilitation completion was significantly shorter in the DCS group (ACS vs. DCS = 10.7 ± 1.2 vs. 9.6 ± 1.5 days, p = 0.047), and the length of hospitalization was significantly shorter in the DCS group (ACS vs. DCS = 21.9 ± 5.3 vs. 18.8 ± 7.2 days, p = 0.031).

Conclusions

This study provided evidence that DCS might be effective for patients who underwent cardiac valve surgery.



中文翻译:

数字胸腔引流系统在心脏瓣膜手术中的临床疗效

对象

便携式数字化吸引器广泛应用于胸外科。该研究的目的是了解心脏手术后使用便携式数字化吸引系统的早期结果。

方法

我们投资了 80 名患者,其中包括 30 名女性(平均年龄 72.7 ± 9.2 岁),她们在我院接受了心脏手术,不包括仅冠状动脉旁路移植术、进行或仅进行主动脉手术、急诊手术和血液透析患者。将患者分为数字胸腔引流系统(DCS组,n  = 38)或模拟胸腔引流系统(ACS组,n  = 42)治疗,并将以下数据分为两组进行分析。主要终点是胸腔引流的持续时间,次要终点是引流相关并发症的发生率和住院时间。

结果

DCS 组的引流持续时间显着缩短(ACS 与 DCS = 94.8 ± 31.5 vs. 81.1 ± 20.6 h,p  = 0.036)。DCS 组完成康复所需的时间显着缩短(ACS vs. DCS = 10.7 ± 1.2 vs. 9.6 ± 1.5 天,p  = 0.047),并且 DCS 组的住院时间明显缩短(ACS vs. DCS = 21.9 ± 5.3 与 18.8 ± 7.2 天,p  = 0.031)。

结论

这项研究提供的证据表明 DCS 可能对接受心脏瓣膜手术的患者有效。

更新日期:2021-11-30
down
wechat
bug